ARANESP
ARANESP
Approved
DIN Number
02392313
Drug Class
Human
Market Date
Aug 16, 2013
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02392313
AIG Number0148081002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B03XA02 DARBEPOETIN ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Subcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DARBEPOETIN ALFAActive
Strength: 25 MCG / ML
Monograph: DARBEPOETIN ALFA